BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,881,940 | -75.7% | 76,363 | -70.6% | 0.01% | -76.0% |
| Q2 2023 | $11,842,047 | +275.9% | 259,922 | +234.7% | 0.05% | +257.1% |
| Q1 2023 | $3,150,214 | +12908.3% | 77,668 | -83.7% | 0.01% | -87.6% |
| Q4 2022 | $24,217 | +59.3% | 475,120 | +68.4% | 0.11% | +52.7% |
| Q3 2022 | $15,200 | -99.9% | 282,210 | -24.0% | 0.07% | -33.3% |
| Q2 2022 | $23,853,000 | +5.0% | 371,378 | +26.8% | 0.11% | +27.6% |
| Q1 2022 | $22,710,000 | -52.8% | 292,885 | -47.7% | 0.09% | -50.8% |
| Q4 2021 | $48,093,000 | -54.0% | 560,262 | -56.9% | 0.18% | -56.7% |
| Q3 2021 | $104,621,000 | +140.9% | 1,300,765 | +141.1% | 0.41% | +146.4% |
| Q2 2021 | $43,435,000 | +473.4% | 539,568 | +500.7% | 0.17% | +435.5% |
| Q1 2021 | $7,575,000 | -61.1% | 89,816 | -63.0% | 0.03% | -62.7% |
| Q4 2020 | $19,494,000 | -70.6% | 242,944 | -70.5% | 0.08% | -73.1% |
| Q3 2020 | $66,253,000 | +8.5% | 823,838 | +16.2% | 0.31% | +3.0% |
| Q2 2020 | $61,055,000 | +21.3% | 709,122 | +14.4% | 0.30% | +5.7% |
| Q1 2020 | $50,341,000 | +55.1% | 620,037 | +59.8% | 0.28% | +97.9% |
| Q4 2019 | $32,447,000 | -24.9% | 388,033 | -21.4% | 0.14% | -28.5% |
| Q3 2019 | $43,196,000 | +4.5% | 493,828 | -2.1% | 0.20% | -2.0% |
| Q2 2019 | $41,330,000 | -46.1% | 504,646 | -46.4% | 0.20% | -46.0% |
| Q1 2019 | $76,614,000 | +24.4% | 942,245 | +0.7% | 0.38% | +12.5% |
| Q4 2018 | $61,584,000 | +378.8% | 935,648 | +460.8% | 0.34% | +441.9% |
| Q3 2018 | $12,862,000 | -66.8% | 166,844 | -68.2% | 0.06% | -68.4% |
| Q2 2018 | $38,687,000 | +36.0% | 523,920 | +19.8% | 0.20% | +35.2% |
| Q1 2018 | $28,439,000 | +5.7% | 437,255 | +5.0% | 0.14% | +20.8% |
| Q4 2017 | $26,907,000 | +1.5% | 416,263 | -1.5% | 0.12% | -11.1% |
| Q3 2017 | $26,507,000 | -7.7% | 422,407 | -10.9% | 0.14% | -2.2% |
| Q2 2017 | $28,711,000 | +30.7% | 474,252 | +12.0% | 0.14% | +32.7% |
| Q1 2017 | $21,968,000 | +63.3% | 423,593 | +39.6% | 0.10% | +46.5% |
| Q4 2016 | $13,450,000 | -8.7% | 303,333 | -2.0% | 0.07% | 0.0% |
| Q3 2016 | $14,727,000 | +50.3% | 309,392 | +42.7% | 0.07% | +42.0% |
| Q2 2016 | $9,801,000 | +9.3% | 216,744 | -0.7% | 0.05% | -3.8% |
| Q1 2016 | $8,968,000 | +206.0% | 218,299 | +184.1% | 0.05% | +205.9% |
| Q4 2015 | $2,931,000 | +7.5% | 76,829 | -7.4% | 0.02% | 0.0% |
| Q3 2015 | $2,727,000 | -77.1% | 83,000 | -51.3% | 0.02% | -74.2% |
| Q2 2015 | $11,920,000 | -67.3% | 170,454 | -68.0% | 0.07% | -66.0% |
| Q1 2015 | $36,455,000 | +446.0% | 532,176 | +484.2% | 0.19% | +438.9% |
| Q4 2014 | $6,677,000 | -73.3% | 91,100 | -73.8% | 0.04% | -74.8% |
| Q3 2014 | $24,994,000 | -53.8% | 348,249 | -53.5% | 0.14% | -53.3% |
| Q2 2014 | $54,091,000 | +693.0% | 748,149 | +707.1% | 0.31% | +665.0% |
| Q1 2014 | $6,821,000 | +4.9% | 92,700 | -0.9% | 0.04% | +8.1% |
| Q4 2013 | $6,503,000 | -56.0% | 93,500 | -58.4% | 0.04% | -58.9% |
| Q3 2013 | $14,763,000 | – | 224,730 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |